关于我们

欧盟评估转基因米曲霉菌株NZYM-MK生产的羧肽酶 D的安全性

放大字体  缩小字体 发布日期:2024-05-27  来源:   作者:泽夕  浏览次数:64
核心提示:2024年5月24日,欧盟食品安全局就一种羧肽酶 D(carboxypeptidase D)的安全性评价发布意见。
     2024年5月24日,欧盟食品安全局就一种羧肽酶 D(carboxypeptidase D)的安全性评价发布意见。
 
  据了解,这种食品酶是由转基因米曲霉菌株NZYM-MK生产的,旨在用于五种食品生产过程。
 
  经过评估,专家小组认为,在预期的使用条件下,不能排除饮食暴露引起过敏反应的风险,特别是对小麦过敏的人,但不会超过食用小麦的风险。根据所提供的数据,评估小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
 
  The food enzyme carboxypeptidase D (EC 3.4.16.6) is produced with the genetically modified Aspergillus oryzae strain NZYM-MK by Novozymes A/S. It is free from viable cells of the production organism and its DNA. The genetic modifications do not give rise to safety concerns. The food enzyme is intended to be used in five food manufacturing processes. Dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.908 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 2220 mg TOS/kg bw per day, the highest dose tested, which, when compared with the estimated dietary exposure, resulted in a margin of exposure of at least 2445. A search for the similarity of the amino acid sequence of the food enzyme to known allergens was made and two matches were found, one with a food allergen (wheat). The Panel considered that a risk of allergic reactions upon dietary exposure to this food enzyme, particularly in individuals sensitised to wheat, cannot be excluded, but will not exceed that of wheat consumption. based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
 
  本文由 食品资讯中心编辑,有任何疑问,请联系news@foodmate.net。
 
 

电话:(010)68869850/(0535)6736261

QQ:3112742182

邮箱:media@foodmate.net

鲁公网安备 37060202000936号

Baidu
map